Company Description
Cresco Labs Inc., together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States.
It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co. brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand.
The company also offers cannabis flowers under the FloraCal brand; and chocolate and toffee confections and fruit-forward gummies under the Mindy’s Edibles brand, as well as licenses the Kiva brand, which produces cannabis infused edibles, including chocolate confections, gummies, mints, and tarts.
In addition, the company offers cannabis-infused edibles under the Sunnyside brand. The company was incorporated in 1990 and is headquartered in Chicago, Illinois.
| Country | United States |
| Founded | 2013 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 2,760 |
| CEO | Charles Bachtell |
Contact Details
Address: 600 W. Fulton Street, Suite 800 Chicago, Illinois 60661 United States | |
| Phone | (312) 929-0993 |
| Website | crescolabs.com |
Stock Details
| Ticker Symbol | CRLBF |
| Exchange | OTCMKTS |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001832928 |
| CUSIP Number | 22587M106 |
| ISIN Number | CA22587M1068 |
| Employer ID | 98-1505364 |
| SIC Code | 2833 |
Key Executives
| Name | Position |
|---|---|
| Charles Bachtell | Co-Founder, Chief Executive Officer and Director |
| Robert M. Sampson | Co-Founder and Independent Director |
| Dennis M. Olis | Chief Financial Officer |
| Gregory Butler | President and Chief Transformation Officer |
| Ty Gent | Chief Operating Officer |
| Zach Marburger | Chief Information Officer |
| Megan Kulick | Senior Vice President of Investor Relations |
| John Schetz | General Counsel |
| Jason Erkes | Chief Communications Officer |
| Angie Demchenko | Chief People Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jul 11, 2024 | 6-K | Report of foreign issuer |
| Jun 10, 2024 | 6-K | Report of foreign issuer |
| May 16, 2024 | 6-K | Report of foreign issuer |
| May 8, 2024 | CB/A | Filing |
| Apr 12, 2024 | CB/A | Filing |
| Apr 10, 2024 | CB | Filing |
| Mar 18, 2024 | 40-F | Filing |
| Mar 13, 2024 | 6-K | Report of foreign issuer |
| Feb 16, 2024 | SC 13D | General statement of acquisition of beneficial ownership |
| Feb 16, 2024 | SC 13D | General statement of acquisition of beneficial ownership |